TERM ID="NYU_TERM_1" STRING="Clinical Excellence" FREQUENCY=1 START=348 END=367 LEMMA="CLINICAL EXCELLENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Final guidance" FREQUENCY=1 START=3143 END=3157 LEMMA="FINAL GUIDANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Higher proportions" FREQUENCY=1 START=609 END=627 LEMMA="HIGHER PROPORTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Higher proportions of participants" FREQUENCY=1 START=609 END=643 LEMMA="PARTICIPANT HIGHER PROPORTION" LEMMA_FREQUENCY=1 HEAD_TERM="Higher proportions" HEAD_LEMMA="HIGHER PROPORTION"
TERM ID="NYU_TERM_5" STRING="MTC" FREQUENCY=2 START=1267 END=1270 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_6" STRING="MTC" FREQUENCY=2 START=1347 END=1350 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="PASI" FREQUENCY=5 START=785 END=789 LEMMA="PASI" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_8" STRING="PASI" FREQUENCY=5 START=808 END=812 LEMMA="PASI" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_9" STRING="PASI" FREQUENCY=5 START=929 END=933 LEMMA="PASI" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_10" STRING="PASI" FREQUENCY=5 START=941 END=945 LEMMA="PASI" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_11" STRING="PASI" FREQUENCY=5 START=998 END=1002 LEMMA="PASI" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_12" STRING="Psoriasis Area" FREQUENCY=1 START=750 END=764 LEMMA="PSORIASIS AREA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="Psoriasis Area and Severity Index" FREQUENCY=1 START=750 END=783 LEMMA="PSORIASIS AREA AND SEVERITY INDEX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="QALY" FREQUENCY=1 START=2073 END=2077 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="RCTs" FREQUENCY=1 START=510 END=514 LEMMA="RANDOMISED CONTROLLED TRIALS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="STA" FREQUENCY=1 START=419 END=422 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="STA states" FREQUENCY=1 START=3010 END=3020 LEMMA="STA STATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="Severity Index" FREQUENCY=1 START=769 END=783 LEMMA="SEVERITY INDEX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="Ustekinumab" FREQUENCY=1 START=0 END=11 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_20" STRING="appropriateness" FREQUENCY=1 START=1286 END=1301 LEMMA="APPROPRIATENES" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="base-case" FREQUENCY=1 START=1937 END=1946 LEMMA="BASE-CASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="base-case analysis" FREQUENCY=1 START=1878 END=1896 LEMMA="BASE-CASE ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="base-case incremental cost-effectiveness ratio" FREQUENCY=1 START=1937 END=1983 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO BASE-CASE" LEMMA_FREQUENCY=1 HEAD_TERM="incremental cost-effectiveness ratio" HEAD_LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO"
TERM ID="NYU_TERM_24" STRING="baseline weight" FREQUENCY=1 START=2413 END=2428 LEMMA="BASELINE WEIGHT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="biological therapies" FREQUENCY=1 START=1708 END=1728 LEMMA="BIOLOGICAL THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="clinical effectiveness" FREQUENCY=2 START=143 END=165 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="clinical effectiveness" FREQUENCY=2 START=2842 END=2864 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_28" STRING="clinical effectiveness estimates" FREQUENCY=1 START=1805 END=1837 LEMMA="CLINICAL EFFECTIVENESS ESTIMATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="comparators" FREQUENCY=1 START=2810 END=2821 LEMMA="COMPARATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="continuous etanercept" FREQUENCY=1 START=2483 END=2504 LEMMA="CONTINUOUS ETANERCEPT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="controlled trials" FREQUENCY=1 START=491 END=508 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="conventional NICE thresholds" FREQUENCY=1 START=2627 END=2655 LEMMA="CONVENTIONAL NICE THRESHOLD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="cost estimate" FREQUENCY=1 START=2209 END=2222 LEMMA="COST ESTIMATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="cost-effectiveness" FREQUENCY=2 START=170 END=188 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_35" STRING="cost-effectiveness" FREQUENCY=2 START=2869 END=2887 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_36" STRING="cost-effectiveness of ustekinumab" FREQUENCY=2 START=170 END=203 LEMMA="USTEKINUMAB COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_37" STRING="cost-effectiveness of ustekinumab" FREQUENCY=2 START=2869 END=2902 LEMMA="USTEKINUMAB COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_38" STRING="economic model" FREQUENCY=1 START=1633 END=1647 LEMMA="ECONOMIC MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="etanercept" FREQUENCY=3 START=708 END=718 LEMMA="ETANERCEPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_40" STRING="etanercept" FREQUENCY=3 START=983 END=993 LEMMA="ETANERCEPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_41" STRING="etanercept" FREQUENCY=3 START=2240 END=2250 LEMMA="ETANERCEPT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_42" STRING="etanercept for PASI" FREQUENCY=1 START=983 END=1002 LEMMA="PASI ETANERCEPT" LEMMA_FREQUENCY=1 HEAD_TERM="etanercept" HEAD_LEMMA="ETANERCEPT"
TERM ID="NYU_TERM_43" STRING="etanercept groups" FREQUENCY=1 START=1543 END=1560 LEMMA="ETANERCEPT GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="evidence review group" FREQUENCY=1 START=99 END=120 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="incremental cost-effectiveness ratio" FREQUENCY=1 START=1947 END=1983 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="kg" FREQUENCY=1 START=2435 END=2437 LEMMA="KG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="life-year" FREQUENCY=1 START=2062 END=2071 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="manufacturer" FREQUENCY=3 START=280 END=293 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_49" STRING="manufacturer" FREQUENCY=3 START=1212 END=1224 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_50" STRING="manufacturer" FREQUENCY=3 START=1617 END=1630 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_51" STRING="methodological aspects" FREQUENCY=1 START=1317 END=1339 LEMMA="METHODOLOGICAL ASPECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="methodological aspects of the MTC" FREQUENCY=1 START=1317 END=1350 LEMMA="MIXED TREATMENT COMPARISON METHODOLOGICAL ASPECT" LEMMA_FREQUENCY=1 HEAD_TERM="methodological aspects" HEAD_LEMMA="METHODOLOGICAL ASPECT"
TERM ID="NYU_TERM_53" STRING="methodological quality" FREQUENCY=1 START=531 END=553 LEMMA="METHODOLOGICAL QUALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="mg" FREQUENCY=6 START=673 END=675 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_55" STRING="mg" FREQUENCY=6 START=683 END=685 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_56" STRING="mg" FREQUENCY=6 START=2254 END=2256 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_57" STRING="mg" FREQUENCY=6 START=2377 END=2379 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_58" STRING="mg" FREQUENCY=6 START=2508 END=2510 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_59" STRING="mg" FREQUENCY=6 START=2758 END=2760 LEMMA="MG" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_60" STRING="mixed treatment comparison" FREQUENCY=1 START=1239 END=1265 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_61" STRING="one-way sensitivity analysis" FREQUENCY=1 START=2083 END=2111 LEMMA="ONE-WAY SENSITIVITY ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="participants" FREQUENCY=1 START=631 END=643 LEMMA="PARTICIPANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_63" STRING="plaque psoriasis" FREQUENCY=1 START=3091 END=3107 LEMMA="PLAQUE PSORIASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="probabilistic sensitivity analysis ustekinumab" FREQUENCY=1 START=2525 END=2571 LEMMA="PROBABILISTIC SENSITIVITY ANALYSIS USTEKINUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="probability" FREQUENCY=1 START=2588 END=2599 LEMMA="PROBABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="psoriasis" FREQUENCY=2 START=52 END=61 LEMMA="PSORIASI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_67" STRING="psoriasis" FREQUENCY=2 START=244 END=253 LEMMA="PSORIASI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_68" STRING="quality-adjusted life-year" FREQUENCY=1 START=2045 END=2071 LEMMA="QUALITY-ADJUSTED LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_69" STRING="randomised controlled trials" FREQUENCY=1 START=480 END=508 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="relative risk" FREQUENCY=1 START=2446 END=2459 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="scenario analysis" FREQUENCY=1 START=2299 END=2316 LEMMA="SCENARIO ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="single technology appraisal" FREQUENCY=1 START=390 END=417 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_73" STRING="statistical analysis" FREQUENCY=1 START=1133 END=1153 LEMMA="STATISTICAL ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="statistical comparisons" FREQUENCY=1 START=1571 END=1594 LEMMA="STATISTICAL COMPARISON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_75" STRING="subgroup" FREQUENCY=1 START=1030 END=1038 LEMMA="SUBGROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_76" STRING="subgroup analysis" FREQUENCY=1 START=1847 END=1864 LEMMA="SUBGROUP ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_77" STRING="supportive care" FREQUENCY=2 START=2007 END=2022 LEMMA="SUPPORTIVE CARE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_78" STRING="supportive care" FREQUENCY=2 START=2188 END=2203 LEMMA="SUPPORTIVE CARE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_79" STRING="technology appraisal" FREQUENCY=1 START=397 END=417 LEMMA="TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_80" STRING="treatment comparison" FREQUENCY=1 START=1245 END=1265 LEMMA="TREATMENT COMPARISON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_81" STRING="treatment option" FREQUENCY=1 START=3058 END=3074 LEMMA="TREATMENT OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_82" STRING="ustekinumab" FREQUENCY=10 START=192 END=203 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_83" STRING="ustekinumab" FREQUENCY=10 START=657 END=668 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_84" STRING="ustekinumab" FREQUENCY=10 START=900 END=911 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_85" STRING="ustekinumab" FREQUENCY=10 START=966 END=977 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_86" STRING="ustekinumab" FREQUENCY=10 START=1508 END=1519 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_87" STRING="ustekinumab" FREQUENCY=10 START=1988 END=1999 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_88" STRING="ustekinumab" FREQUENCY=10 START=2362 END=2373 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_89" STRING="ustekinumab" FREQUENCY=10 START=2743 END=2754 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_90" STRING="ustekinumab" FREQUENCY=10 START=2891 END=2902 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_91" STRING="ustekinumab" FREQUENCY=10 START=3026 END=3037 LEMMA="USTEKINUMAB" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_92" STRING="utility scores" FREQUENCY=1 START=2265 END=2279 LEMMA="UTILITY SCORE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_93" STRING="weight threshold" FREQUENCY=1 START=1176 END=1192 LEMMA="WEIGHT THRESHOLD" LEMMA_FREQUENCY=1
